Simon Timothy M, Jackson Douglas W
Orthopaedic Research Institute and the Southern California Center for Sports Medicine, Long Beach, CA 90806, USA.
Sports Med Arthrosc Rev. 2006 Sep;14(3):146-54. doi: 10.1097/00132585-200609000-00006.
Articular cartilage injury and degeneration is a frequent occurrence in synovial joints. Treatment of these articular cartilage lesions are a challenge because this tissue is incapable of quality repair and/or regeneration to its native state. Nonoperative treatments endeavor to control symptoms, and include anti-inflammatory medication, viscosupplementation, bracing, orthotics, and activity modification. Techniques to stimulate the intrinsic repair (fibrocartilage) process include drilling, abrasion, and microfracture of the subchondral bone. Currently, the clinical biologic approaches to treat cartilage defects include autologous chondrocyte implantation, periosteal transfer, and osteochondral autograft or allograft transplantation. Newer strategies employing tissue engineering being studied involve the use of combinations of progenitor cells, bioactive factors, and matrices, and the use of focal synthetic devices. Many new and innovative treatments are being explored in this exciting field. However, there is a paucity of prospective, randomized controlled clinical trials that have compared the various techniques, treatment options, indications and efficacy.
关节软骨损伤和退变在滑膜关节中很常见。这些关节软骨损伤的治疗颇具挑战性,因为这种组织无法完全修复和/或再生至其天然状态。非手术治疗旨在控制症状,包括使用抗炎药物、关节腔注射透明质酸钠、支具、矫形器以及调整活动方式。刺激内在修复(纤维软骨)过程的技术包括钻孔、磨削和软骨下骨微骨折。目前,治疗软骨缺损的临床生物学方法包括自体软骨细胞植入、骨膜移植以及自体或异体骨软骨移植。正在研究的采用组织工程的新策略涉及祖细胞、生物活性因子和基质的联合应用,以及局部合成装置的使用。在这个令人兴奋的领域中,许多新的和创新的治疗方法正在被探索。然而,比较各种技术、治疗选择、适应证和疗效的前瞻性、随机对照临床试验却很少。